Octagam Immune Globulin (human) Solution
Product Images NDC 0069-6002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Octagam Immune Globulin (human) (NDC 0069-6002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image File (Img0001)

Image File (Img0001)
The text provided contains information about the in vitro reduction factor [logso] for different production steps and the efficacy of these steps in reducing enveloped and non-enveloped viruses, specifically HIV-1 PRV SBV MEV PPV. Cold ethanol fractionation yielded reduction factors of 24.81, >6.28, >7.13, >7.13, and 2653 for enveloped viruses, while S/D treatment resulted in reduction factors of 2493, 523, 677 for non-enveloped viruses. pH4 treatment showed reduction factors of 24.33, 26.71, 6.71, 5.07, and L5 for enveloped viruses. Overall, the global reduction factor was >14.07, >18.22, 22061, >12.20, and >6.53 for the mentioned viruses.*
FDA Label Image

Image File (Img0002)

Image File (Img0002)
FDA Label Image

Image File (Img0003)

Image File (Img0003)
FDA Label Image

Image File (Img0004)

Image File (Img0004)
FDA Label Image

Image File (Img0005)

Image File (Img0005)
FDA Label Image

Image File (Img0006)

Image File (Img0006)
FDA Label Image

Image File (Img0007)

Image File (Img0007)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.